James Mulshine to Humans
This is a "connection" page, showing publications James Mulshine has written about Humans.
Connection Strength
1.822
-
Emphysema Detection in the Course of Lung Cancer Screening: Optimizing a Rare Opportunity to Impact Population Health. Ann Am Thorac Soc. 2023 04; 20(4):499-503.
Score: 0.049
-
The Long, Slow Road to Lung Cancer Cure. JAMA Oncol. 2021 12 01; 7(12):1765-1767.
Score: 0.044
-
Thoracic CT screening: using routinely detectable COPD information. Clin Imaging. 2021 Oct; 78:310-312.
Score: 0.043
-
The International Association for the Study of Lung Cancer Early Lung Imaging Confederation. JCO Clin Cancer Inform. 2020 02; 4:89-99.
Score: 0.039
-
One Screening for Ischemic Heart Disease, Lung Cancer, and Chronic Obstructive Pulmonary Disease: A Systems Biology Bridge for Tobacco and Radiation Exposure. Am J Public Health. 2018 10; 108(10):1294-1295.
Score: 0.036
-
Moonshot Acceleration Factor: Medical Imaging. Cancer Res. 2017 11 01; 77(21):5717-5720.
Score: 0.033
-
Lung Cancer Workshop XI: Tobacco-Induced Disease: Advances in Policy, Early Detection and Management. J Thorac Oncol. 2015 May; 10(5):762-767.
Score: 0.028
-
Role of the Quantitative Imaging Biomarker Alliance in optimizing CT for the evaluation of lung cancer screen-detected nodules. J Am Coll Radiol. 2015 Apr; 12(4):390-5.
Score: 0.028
-
Shared decision making and screening: an ongoing dialogue informed by data. Oncology (Williston Park). 2015 Mar; 29(3):149.
Score: 0.028
-
Lung cancer screening with low-dose CT: more questions than answers--author's reply. Lancet Oncol. 2015 Jan; 16(1):e4.
Score: 0.028
-
Evaluation of an interactive science publishing tool: toward enabling three-dimensional analysis of medical images. Acad Radiol. 2015 Mar; 22(3):380-6.
Score: 0.027
-
Lung cancer screening: achieving more by intervening less. Lancet Oncol. 2014 Nov; 15(12):1284-5.
Score: 0.027
-
Issues with implementing a high-quality lung cancer screening program. CA Cancer J Clin. 2014 Sep-Oct; 64(5):352-63.
Score: 0.027
-
Tobacco control since the 1964 Surgeon General's Report: reflecting back and looking forward. Oncology (Williston Park). 2014 Mar; 28(3):180, 182-3, 210.
Score: 0.026
-
Application of high-resolution CT imaging data to lung cancer drug development: measuring progress: workshop IX. J Thorac Oncol. 2013 Nov; 8(11):1352-5.
Score: 0.025
-
Advancing patient-centric genomic medicine. Oncology (Williston Park). 2013 Sep; 27(9):827.
Score: 0.025
-
Not significant but important. Cancer Prev Res (Phila). 2013 May; 6(5):371-4.
Score: 0.025
-
Lessons from considering the cancer landscape. Oncology (Williston Park). 2013 May; 27(5):408, 410.
Score: 0.025
-
An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood). 2012 Apr; 31(4):770-9.
Score: 0.023
-
Lung cancer screening: what is the benefit and what do we do about it? Lung Cancer. 2011 Mar; 71(3):247-8.
Score: 0.021
-
hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. Cancer Res. 2010 Sep 15; 70(18):7137-47.
Score: 0.020
-
Introduction: Imaging in diagnosis and treatment of lung cancer. Opt Express. 2010 Jul 05; 18(14):15242-3.
Score: 0.020
-
A quantitative method for estimating individual lung cancer risk. Acad Radiol. 2010 Jul; 17(7):830-40.
Score: 0.020
-
Cytokines and growth factors stimulate hyaluronan production: role of hyaluronan in epithelial to mesenchymal-like transition in non-small cell lung cancer. J Biomed Biotechnol. 2010; 2010:485468.
Score: 0.020
-
Volume CT for diagnosis of nodules found in lung-cancer screening. N Engl J Med. 2009 Dec 03; 361(23):2281-2.
Score: 0.019
-
Lung cancer and inflammation: interaction of chemokines and hnRNPs. Curr Opin Pharmacol. 2009 Aug; 9(4):384-8.
Score: 0.019
-
Use of high-resolution CT imaging data in lung cancer drug development: measuring progress. Oncology (Williston Park). 2009 Apr 30; 23(5):434-8.
Score: 0.019
-
Commentary: lung cancer screening--progress or peril. Oncologist. 2008 Apr; 13(4):435-8.
Score: 0.017
-
Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets. Bioinformatics. 2008 Feb 01; 24(3):389-95.
Score: 0.017
-
Developing CT image-processing tools to accelerate progress in lung cancer drug development. Oncology (Williston Park). 2006 Nov; 20(12):1606, 1608-10, 1614 passim.
Score: 0.016
-
Early lung cancer detection: approaching the 'tipping point'? Oncology (Williston Park). 2006 Nov; 20(12):1632.
Score: 0.016
-
The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group. J Thorac Oncol. 2006 Jun; 1(5):497-8.
Score: 0.015
-
Lung cancer screening. Oncologist. 2006 May; 11(5):481-7.
Score: 0.015
-
Ingenuity network-assisted transcription profiling: Identification of a new pharmacologic mechanism for MK886. Clin Cancer Res. 2006 Mar 15; 12(6):1820-7.
Score: 0.015
-
Current issues in lung cancer screening. Oncology (Williston Park). 2005 Nov; 19(13):1724-30; discussion 1730-1.
Score: 0.015
-
Chemoprevention of head and neck cancer. Clin Adv Hematol Oncol. 2005 Oct; 3(10):763-5.
Score: 0.015
-
Clinical issues in the management of early lung cancer. Clin Cancer Res. 2005 Jul 01; 11(13 Pt 2):4993s-4998s.
Score: 0.014
-
Clinical practice. Lung cancer screening. N Engl J Med. 2005 Jun 30; 352(26):2714-20.
Score: 0.014
-
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition. Cancer Res. 2005 May 15; 65(10):4181-90.
Score: 0.014
-
New developments in lung cancer screening. J Clin Oncol. 2005 May 10; 23(14):3198-202.
Score: 0.014
-
Lung cancer screening: panacea or pipe dream? Ann Oncol. 2005; 16 Suppl 2:ii215-9.
Score: 0.014
-
Epithelial-directed drug delivery: influence of formulation and delivery devices. Lung Cancer. 2004 Dec; 46(3):387-92.
Score: 0.014
-
Is the gene expression pattern of lung cancer detected by screening with spiral computed tomography different from that of symptom-detected lung cancer? Clin Cancer Res. 2004 Sep 15; 10(18 Pt 1):5973-4.
Score: 0.013
-
Lung cancer screening with spiral CT: toward a working strategy. Oncology (Williston Park). 2004 May; 18(5):564-75, discussion 578, 583-4, 587.
Score: 0.013
-
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res. 2004 Mar 01; 10(5):1565-73.
Score: 0.013
-
Surgical considerations with lung cancer screening. J Surg Oncol. 2003 Sep; 84(1):1-6.
Score: 0.013
-
The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative. J Thorac Oncol. 2024 Jan; 19(1):94-105.
Score: 0.013
-
Lung cancer chemoprevention: moving from concept to a reality. Lung Cancer. 2003 Aug; 41 Suppl 1:S163-74.
Score: 0.012
-
The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer. 2003 Jul; 5(1):46-62.
Score: 0.012
-
Screening of mutations in the ras family of oncogenes by polymerase chain reaction-based ligase chain reaction. Methods Mol Med. 2003; 74:187-200.
Score: 0.012
-
Downregulation of hnRNP A2/B1 expression in tumor cells under prolonged hypoxia. Am J Respir Cell Mol Biol. 2003 Jan; 28(1):80-5.
Score: 0.012
-
Screening for lung cancer: in pursuit of pre-metastatic disease. Nat Rev Cancer. 2003 Jan; 3(1):65-73.
Score: 0.012
-
Tobacco money: up in smoke? Lancet. 2002 Dec 14; 360(9349):1979-80; author reply 1981.
Score: 0.012
-
Lung cancer. 2: screening and early diagnosis of lung cancer. Thorax. 2002 Dec; 57(12):1071-8.
Score: 0.012
-
IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001. Lung Cancer. 2002 Sep; 37(3):325-44.
Score: 0.012
-
Radiologic screening for lung cancer. Expert Rev Anticancer Ther. 2002 Aug; 2(4):385-92.
Score: 0.012
-
Lung cancer evolution to preinvasive management. Clin Chest Med. 2002 Mar; 23(1):37-48.
Score: 0.011
-
Moving to the routine management of pre symptomatic lung cancer. Lung Cancer. 2001 Dec; 34 Suppl 2:S1-5.
Score: 0.011
-
Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. 2001 Sep; 15(11):2007-9.
Score: 0.011
-
Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat. 2001 Apr; 66(3):217-24.
Score: 0.011
-
Screening for lung cancer. N Engl J Med. 2001 Mar 22; 344(12):935-6.
Score: 0.011
-
QIBA guidance: Computed tomography imaging for COVID-19 quantitative imaging applications. Clin Imaging. 2021 Sep; 77:151-157.
Score: 0.011
-
Considerations in developing successful, population-based molecular screening and prevention of lung cancer. Cancer. 2000 Dec 01; 89(11 Suppl):2465-7.
Score: 0.010
-
Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations. Am J Respir Cell Mol Biol. 2000 Nov; 23(5):636-45.
Score: 0.010
-
The early detection of occult lung cancer. Chest Surg Clin N Am. 2000 Nov; 10(4):737-49.
Score: 0.010
-
Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation? FASEB J. 2000 Aug; 14(11):1499-507.
Score: 0.010
-
Prospects for lung-cancer screening. Lancet. 2000 Feb 19; 355(9204):592-3.
Score: 0.010
-
New molecular strategies for early lung cancer detection. Cancer Invest. 2000; 18(6):555-63.
Score: 0.010
-
Reducing lung cancer risk: early detection. Chest. 1999 Dec; 116(6 Suppl):493S-496S.
Score: 0.010
-
Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin Cancer Res. 1999 Nov; 5(11):3385-93.
Score: 0.010
-
Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res. 1999 May 01; 59(9):2223-8.
Score: 0.009
-
Reflections on early cancer control efforts. J Surg Oncol. 1999 Apr; 70(4):207-8.
Score: 0.009
-
Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development. Am J Respir Cell Mol Biol. 1998 Oct; 19(4):554-62.
Score: 0.009
-
Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. Exp Lung Res. 1998 Jul-Aug; 24(4):617-28.
Score: 0.009
-
Quality assurance and quantitative imaging biomarkers in low-dose CT lung cancer screening. Br J Radiol. 2018 Oct; 91(1090):20170401.
Score: 0.008
-
Sputum screening by quantitative microscopy: a new dawn for detection of lung cancer? Mayo Clin Proc. 1997 Aug; 72(8):788-90.
Score: 0.008
-
Recent molecular advances in the approach to early lung cancer detection and intervention. Environ Health Perspect. 1997 Jun; 105 Suppl 4:935-9.
Score: 0.008
-
Scientific Advances in Thoracic Oncology 2016. J Thorac Oncol. 2017 08; 12(8):1183-1209.
Score: 0.008
-
Prevention and early detection of lung cancer-clinical aspects. Lung Cancer. 1997 May; 17(1):163-74.
Score: 0.008
-
New approaches to the integrated management of early lung cancer. Hematol Oncol Clin North Am. 1997 Apr; 11(2):235-52.
Score: 0.008
-
High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer. Clin Cancer Res. 1997 Mar; 3(3):479-82.
Score: 0.008
-
Lung cancer: current therapies and new targeted treatments. Lancet. 2017 01 21; 389(10066):299-311.
Score: 0.008
-
Volumes Learned: It Takes More Than Size to "Size Up" Pulmonary Lesions. Acad Radiol. 2016 09; 23(9):1190-8.
Score: 0.008
-
Peptide amidating activity in human bronchoalveolar lavage fluid. Lung Cancer. 1996 Jun; 14(2-3):239-51.
Score: 0.008
-
NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl. 1996; 24:32-91.
Score: 0.007
-
Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells. J Cell Biochem Suppl. 1996; 24:276-87.
Score: 0.007
-
Molecular markers in early cancer detection. New screening tools. Chest. 1995 Jun; 107(6 Suppl):280S-286S.
Score: 0.007
-
Fostering chemopreventive agent development: how to proceed? J Cell Biochem Suppl. 1995; 22:254-9.
Score: 0.007
-
Anticancer antibodies for lung cancer. J Clin Oncol. 1994 Nov; 12(11):2519-20.
Score: 0.007
-
RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene. 1994 Sep; 9(9):2441-8.
Score: 0.007
-
E-cigarettes and cancer patients. J Thorac Oncol. 2014 Apr; 9(4):438-41.
Score: 0.007
-
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance. Lung Cancer. 1994 Mar; 10 Suppl 1:S73-81.
Score: 0.006
-
The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations. J Thorac Oncol. 2014 Feb; 9(2):141-3.
Score: 0.006
-
Cytometric validation of immunocytochemical observations in developing lung cancer. Diagn Cytopathol. 1993 Dec; 9(6):615-22.
Score: 0.006
-
Biochemical characterization of peptide alpha-amidation enzyme activities of human neuroendocrine lung cancer cell lines. Cell Growth Differ. 1993 Nov; 4(11):911-20.
Score: 0.006
-
Scientific basis for cancer prevention. Intermediate cancer markers. Cancer. 1993 Aug 01; 72(3 Suppl):978-83.
Score: 0.006
-
Early detection of lung cancer. Semin Oncol. 1993 Aug; 20(4):374-82.
Score: 0.006
-
Tobacco cessation and control a decade later: American society of clinical oncology policy statement update. J Clin Oncol. 2013 Sep 01; 31(25):3147-57.
Score: 0.006
-
Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013 Sep; 9(5):258-62.
Score: 0.006
-
Monoclonal antibodies for early cytologic detection of lung cancer. Semin Thorac Cardiovasc Surg. 1993 Jul; 5(3):201-9.
Score: 0.006
-
Epidemiology, prognostic factors, and prevention of lung cancer. Curr Opin Oncol. 1993 Mar; 5(2):302-9.
Score: 0.006
-
Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan). Mol Carcinog. 1993; 8(4):214-20.
Score: 0.006
-
Initiators and promoters of lung cancer. Chest. 1993 Jan; 103(1 Suppl):4S-11S.
Score: 0.006
-
Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: assays for promotion factors in the bronchial lavage. J Cell Biochem Suppl. 1993; 17F:175-83.
Score: 0.006
-
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg. 2012 Jul; 144(1):25-32.
Score: 0.006
-
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012 Jul; 144(1):33-8.
Score: 0.006
-
The correct dose: pharmacologically guided end point for anti-growth factor therapy. Cancer Res. 1992 May 01; 52(9 Suppl):2743s-2746s.
Score: 0.006
-
Overview: NCI Workshop on Investigational Strategies for Detection and Intervention in Early Lung Cancer. Cancer Res. 1992 May 01; 52(9 Suppl):2639s-2640s.
Score: 0.006
-
Considerations in bringing a cancer biomarker to clinical application. Cancer Res. 1992 May 01; 52(9 Suppl):2711s-2718s.
Score: 0.006
-
Diagnostic research: breakout group report. Cancer Res. 1992 May 01; 52(9 Suppl):2766s.
Score: 0.006
-
Rational targets for the early detection of lung cancer. J Natl Cancer Inst Monogr. 1992; (13):183-90.
Score: 0.006
-
Growth factors and other targets for rational application as intervention agents. Adv Exp Med Biol. 1992; 320:81-8.
Score: 0.006
-
Candidate biomarkers for application as intermediate end points of lung carcinogenesis. J Cell Biochem Suppl. 1992; 16G:183-6.
Score: 0.006
-
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol. 2012 Jan; 7(1):10-9.
Score: 0.006
-
Lung cancer: rational strategies for early detection and intervention. Oncology (Williston Park). 1991 May; 5(5):25-32; discussion 32-3, 37.
Score: 0.005
-
Direct intralymphatic injection of radiolabeled 111In-T101 in patients with cutaneous T-cell lymphoma. Cancer Res. 1991 Jan 15; 51(2):688-95.
Score: 0.005
-
Need for uniformity in collection and reporting of data in cancer clinical trials. J Natl Cancer Inst. 1990 Sep 05; 82(17):1377-8.
Score: 0.005
-
Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci U S A. 1990 Sep; 87(17):6698-702.
Score: 0.005
-
A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity. Am J Clin Oncol. 1990 Aug; 13(4):285-9.
Score: 0.005
-
An actuarial approach to comparing early stage and late stage lung cancer mortality and survival. Popul Health Manag. 2010 Feb; 13(1):33-46.
Score: 0.005
-
The use of volumetric CT as an imaging biomarker in lung cancer. Acad Radiol. 2010 Jan; 17(1):100-6.
Score: 0.005
-
Autocrine growth factors as therapeutic targets in lung cancer. Chest. 1989 Jul; 96(1 Suppl):31S-34S.
Score: 0.005
-
Considerations in the development of lung cancer screening tools. J Natl Cancer Inst. 1989 Jun 21; 81(12):900-6.
Score: 0.005
-
Peptide structure. Beyond transcriptional events. Nature. 1989 Feb 02; 337(6206):406.
Score: 0.005
-
In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung. Int J Rad Appl Instrum B. 1989; 16(2):159-62.
Score: 0.005
-
Autocrine growth factors and lung cancer. Cancer Treat Res. 1989; 45:107-22.
Score: 0.005
-
Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol. 1988 Nov; 6(11):1685-93.
Score: 0.004
-
Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation. Anal Biochem. 1988 Oct; 174(1):224-34.
Score: 0.004
-
Identifying prognostic factors in binary outcome data: an application using liver function tests and age to predict liver metastases. Stat Med. 1988 Aug; 7(8):843-56.
Score: 0.004
-
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer. 2008 Sep; 61(3):340-9.
Score: 0.004
-
Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transferrin-like factor mediate autocrine growth? Exp Cell Biol. 1988; 56(1-2):74-85.
Score: 0.004
-
Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer. Ann N Y Acad Sci. 1988; 547:360-72.
Score: 0.004
-
Consideration of the chemistry of solid-phase matrix interaction leads to improved quantitation of neuropeptides. Ann N Y Acad Sci. 1988; 547:41-53.
Score: 0.004
-
Biomedical imaging archive network. Skeletal Radiol. 2007 Sep; 36(9):799-801.
Score: 0.004
-
Treatment of non-small-cell lung cancer. J Clin Oncol. 1986 Nov; 4(11):1704-15.
Score: 0.004
-
Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment. J Thorac Oncol. 2006 Nov; 1(9 Suppl):S20-6.
Score: 0.004
-
Biochemical and ultrastructural study of Leu M1 antigen in Reed-Sternberg cells: comparison with granulocytes and interdigitating reticulum cells. J Natl Cancer Inst. 1986 Aug; 77(2):363-70.
Score: 0.004
-
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement. Clin Cancer Res. 2005 Jul 01; 11(13 Pt 2):4981s-4983s.
Score: 0.004
-
cDNA expression profiling reveals elevated gene expression in cell clusters overlying focally disrupted myoepithelial cell layers: implications for breast tumor invasion. Breast Cancer Res Treat. 2005 Jan; 89(2):199-208.
Score: 0.003
-
A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect Prev. 2005; 29(4):323-31.
Score: 0.003
-
Clinical significance of the association of the Von Hippel-Lindau disease with pheochromocytoma and pancreatic apudoma. Am J Med Sci. 1984 Dec; 288(5):212-6.
Score: 0.003
-
Differential oblique angle spectroscopy of the oral epithelium. J Biomed Opt. 2004 Sep-Oct; 9(5):951-60.
Score: 0.003
-
Diagnosis and significance of liver metastases in small cell carcinoma of the lung. J Clin Oncol. 1984 Jul; 2(7):733-41.
Score: 0.003
-
Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. J Immunol. 1983 Jul; 131(1):497-502.
Score: 0.003
-
Lung cancer screening by spiral CT. What is the optimal target population for screening trials? Lung Cancer. 2002 Dec; 38(3):243-52.
Score: 0.003
-
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. Int J Oncol. 2002 Aug; 21(2):369-73.
Score: 0.003
-
Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. Lung Cancer. 2001 Dec; 34(3):341-50.
Score: 0.003
-
Platelet-bound IgG in systemic lupus erythematosus with and without thrombocytopenia. J Immunol Methods. 1981; 45(3):275-81.
Score: 0.003
-
Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors. Clin Cancer Res. 2000 Sep; 6(9):3636-45.
Score: 0.003
-
Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors. Lung Cancer. 1999 Mar; 23(3):209-22.
Score: 0.002
-
5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death. Prostate. 1998 Nov 01; 37(3):161-73.
Score: 0.002
-
Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma. Clin Cancer Res. 1998 Nov; 4(11):2691-700.
Score: 0.002
-
Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res. 1998 Jul; 4(7):1631-40.
Score: 0.002
-
Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. Anticancer Res. 1998 Mar-Apr; 18(2A):775-82.
Score: 0.002
-
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2237-46.
Score: 0.002
-
Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest. 1997 Jul; 112(1):256-61.
Score: 0.002
-
Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction. Anal Biochem. 1996 Aug 01; 239(2):153-9.
Score: 0.002
-
Preliminary results for positron emission mammography: real-time functional breast imaging in a conventional mammography gantry. Eur J Nucl Med. 1996 Jul; 23(7):804-6.
Score: 0.002
-
Insulin-like growth factor expression in human cancer cell lines. J Biol Chem. 1996 May 10; 271(19):11477-83.
Score: 0.002
-
Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J Biol Chem. 1996 May 03; 271(18):10760-6.
Score: 0.002
-
Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol. 1996 Mar; 14(3):806-13.
Score: 0.002
-
Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium. Lung Cancer. 1996 Feb; 14(1):85-97.
Score: 0.002
-
Dipyridamole mediated enhanced antiproliferative activity of 10-ethyl-10-deazaaminopterin (10-EDAM) against human lung cancer cell lines. J Cell Biochem Suppl. 1996; 24:165-72.
Score: 0.002
-
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer. J Cell Biochem Suppl. 1996; 24:173-85.
Score: 0.002
-
Monoclonal antibody alpha IR-3 inhibits non-small cell lung cancer growth in vitro and in vivo. J Cell Biochem Suppl. 1996; 24:269-75.
Score: 0.002
-
Biochemical characterization of mouse liver IBE1-amide immunoreactivity: limitations of antibody-based approaches for verification of peptide expression. Peptides. 1996; 17(5):881-3.
Score: 0.002
-
Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J Natl Cancer Inst. 1995 May 17; 87(10):756-61.
Score: 0.002
-
Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability. Cell Growth Differ. 1995 May; 6(5):485-92.
Score: 0.002
-
Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshop. Lung Cancer. 1995 Mar; 12(1-2):91-103.
Score: 0.002
-
The early detection of second primary lung cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group. Chest. 1994 Dec; 106(6 Suppl):385S-390S.
Score: 0.002
-
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol. 1994 Oct; 12(10):2022-34.
Score: 0.002
-
Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res. 1994 May 01; 54(9):2496-503.
Score: 0.002
-
Pre-operative and post-operative treatments in stage III NSCLC. Lung Cancer. 1994 Mar; 10 Suppl 1:S15-7.
Score: 0.002
-
Second IASLC Workshop on Combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Biological basis of combined therapy. Lung Cancer. 1994 Mar; 10 Suppl 1:S3-5.
Score: 0.002
-
Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium. Cancer Res. 1993 Jan 01; 53(1):67-74.
Score: 0.001
-
Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers. Int J Cancer. 1992 Nov 11; 52(5):718-25.
Score: 0.001
-
A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc Natl Acad Sci U S A. 1992 Sep 01; 89(17):8107-11.
Score: 0.001
-
Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg. 1992 Jun; 53(6):992-8.
Score: 0.001
-
Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features. Am J Clin Pathol. 1992 Feb; 97(2):233-43.
Score: 0.001
-
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene. 1992 Jan; 7(1):171-80.
Score: 0.001
-
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines. J Natl Cancer Inst Monogr. 1992; (13):191-6.
Score: 0.001
-
Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets. J Natl Cancer Inst Monogr. 1992; (13):61-6.
Score: 0.001
-
Alpha-amidation of peptide hormones in lung cancer. Cancer Cells. 1991 Dec; 3(12):504-10.
Score: 0.001
-
ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res. 1991 Sep 15; 51(18):4999-5002.
Score: 0.001
-
Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene. 1991 Aug; 6(8):1353-62.
Score: 0.001
-
Cross validation of cluster analysis using immunostained multi-tissue tumour block slides. Br J Cancer Suppl. 1991 Jun; 14:60-3.
Score: 0.001
-
Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer. Genes Chromosomes Cancer. 1991 May; 3(3):168-88.
Score: 0.001
-
Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res. 1990 Sep 01; 50(17):5481-7.
Score: 0.001
-
Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years. J Clin Oncol. 1990 Jun; 8(6):1042-9.
Score: 0.001
-
Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer. Immunol Ser. 1990; 53:453-68.
Score: 0.001
-
Antibody 624H12, which detects lung cancer at early stages, recognizes a sugar sequence in the glycosphingolipid difucosylneolactonorhexaosylceramide (V3FucIII3FunLc6Cer). Arch Biochem Biophys. 1989 Nov 15; 275(1):309-14.
Score: 0.001
-
MDR1 gene expression in lung cancer. J Natl Cancer Inst. 1989 Aug 02; 81(15):1144-50.
Score: 0.001
-
Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II). Cancer Res. 1989 May 01; 49(9):2390-7.
Score: 0.001
-
Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol. 1988 Dec; 90(6):641-52.
Score: 0.001
-
A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line. Biochem Biophys Res Commun. 1988 Nov 15; 156(3):1383-9.
Score: 0.001
-
Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res. 1988 Jul 15; 48(14):4078-82.
Score: 0.001
-
Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest. 1988 Jul; 82(1):354-9.
Score: 0.001
-
Gastrin-releasing peptide and other autocrine growth factors in lung cancer: pathogenetic and treatment implications. Important Adv Oncol. 1988; 55-64.
Score: 0.001
-
Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells. Cancer Res. 1987 Oct 01; 47(19):5009-13.
Score: 0.001
-
Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphoma. J Nucl Med. 1987 Mar; 28(3):281-7.
Score: 0.001
-
The pharmacology of monoclonal antibodies. Ann N Y Acad Sci. 1987; 507:199-210.
Score: 0.001
-
Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibody. J Nucl Med. 1987 Jan; 28(1):42-6.
Score: 0.001
-
Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody. N Engl J Med. 1986 Sep 11; 315(11):673-80.
Score: 0.001
-
Glycolipid antigen expression in human lung cancer. Cancer Res. 1986 Sep; 46(9):4751-5.
Score: 0.001
-
Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. Cancer Res. 1986 May; 46(5):2633-8.
Score: 0.001
-
Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:843-53.
Score: 0.001
-
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature. 1985 Aug 29-Sep 4; 316(6031):823-6.
Score: 0.001
-
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med. 1985 May 01; 161(5):1135-51.
Score: 0.001
-
Improved antigen detection in ethanol-fixed cytologic specimens. A modified avidin-biotin-peroxidase complex (ABC) method. Diagn Cytopathol. 1985 Apr-Jun; 1(2):133-6.
Score: 0.001
-
Autocrine growth factors in human small cell lung cancer. Cancer Surv. 1985; 4(4):707-27.
Score: 0.001
-
Immunohistochemical localization of the immunodominant differentiation antigen lacto-N-fucopentaose III in normal adult and fetal tissues. J Histochem Cytochem. 1984 Sep; 32(9):982-8.
Score: 0.001
-
Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies. Cancer Res. 1984 May; 44(5):2052-61.
Score: 0.001